Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification.

Breast cancer Cancer metabolism Prognostic markers

Journal

NPJ breast cancer
ISSN: 2374-4677
Titre abrégé: NPJ Breast Cancer
Pays: United States
ID NLM: 101674891

Informations de publication

Date de publication:
2019
Historique:
received: 12 02 2019
accepted: 06 08 2019
entrez: 5 9 2019
pubmed: 5 9 2019
medline: 5 9 2019
Statut: epublish

Résumé

Despite recent refinements to the 21-gene g score, allowing a better identification of patients who may derive no benefit from the addition of adjuvant chemotherapy to that of endocrine therapy, patients with early breast cancer still stand to be over-treated in the setting of clinical and/or genomic uncertainty or discordance. Here we describe and demonstrate a potential approach of further refining the OncotypeDX risk score by metabolomic analysis of serum. In a clinical dataset (

Identifiants

pubmed: 31482106
doi: 10.1038/s41523-019-0123-9
pii: 123
pmc: PMC6715716
doi:

Types de publication

Journal Article

Langues

eng

Pagination

26

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Déclaration de conflit d'intérêts

Competing interestsA.D.L. has received honoraria for attending advisory boards and as a speaker at sponsored symposia by Genomic Health. The other authors declare no competing interests.

Références

Clin Cancer Res. 2017 Mar 15;23(6):1422-1431
pubmed: 28082280
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
Mol Oncol. 2015 Jan;9(1):128-39
pubmed: 25151299
BMC Med. 2019 Jan 7;17(1):3
pubmed: 30616610
Adv Exp Med Biol. 2016;882:217-34
pubmed: 26987537
J Pharm Biomed Anal. 1994 Oct;12(10):1215-25
pubmed: 7841215
N Engl J Med. 2018 Jul 12;379(2):111-121
pubmed: 29860917
Cancer Treat Rev. 2018 Jun;67:88-96
pubmed: 29775779
J Biomol NMR. 2011 Apr;49(3-4):231-43
pubmed: 21380509
N Engl J Med. 2017 Nov 9;377(19):1836-1846
pubmed: 29117498
Anal Biochem. 1994 Aug 1;220(2):284-96
pubmed: 7978270
J Clin Oncol. 2007 Jul 1;25(19):2840-6
pubmed: 17502626
NPJ Breast Cancer. 2019 Aug 29;5:26
pubmed: 31482106
Brief Bioinform. 2013 May;14(3):315-26
pubmed: 22786785
Angew Chem Int Ed Engl. 2019 Jan 21;58(4):968-994
pubmed: 29999221
Ann Oncol. 2011 Jun;22(6):1295-1301
pubmed: 21199886

Auteurs

Amelia McCartney (A)

"Sandro Pitigliani" Department of Medical Oncology, Prato Hospital, Via Suor Niccolina 20, Prato, Italy.

Alessia Vignoli (A)

2Consorzio Interuniversitario Risonanze Magnetiche di Metallo Proteine (C.I.R.M.M.P.), Via Sacconi 6, Sesto Fiorentino, 50019 Italy.
3Centre for Magnetic Resonance (CERM), University of Florence, Via Sacconi 6, Sesto Fiorentino, 50019 Italy.

Leonardo Tenori (L)

3Centre for Magnetic Resonance (CERM), University of Florence, Via Sacconi 6, Sesto Fiorentino, 50019 Italy.
4Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, Florence, 50100 Italy.

Monica Fornier (M)

5Breast Medicine Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY USA.

Lorenzo Rossi (L)

"Sandro Pitigliani" Department of Medical Oncology, Prato Hospital, Via Suor Niccolina 20, Prato, Italy.
Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland.
Breast Unit of Southern Switzerland (CSSI), Lugano, Switzerland.

Emanuela Risi (E)

"Sandro Pitigliani" Department of Medical Oncology, Prato Hospital, Via Suor Niccolina 20, Prato, Italy.

Claudio Luchinat (C)

2Consorzio Interuniversitario Risonanze Magnetiche di Metallo Proteine (C.I.R.M.M.P.), Via Sacconi 6, Sesto Fiorentino, 50019 Italy.
3Centre for Magnetic Resonance (CERM), University of Florence, Via Sacconi 6, Sesto Fiorentino, 50019 Italy.
8Department of Chemistry, University of Florence, Via della Lastruccia 3, Sesto Fiorentino, 50019 Italy.

Laura Biganzoli (L)

"Sandro Pitigliani" Department of Medical Oncology, Prato Hospital, Via Suor Niccolina 20, Prato, Italy.

Angelo Di Leo (A)

"Sandro Pitigliani" Department of Medical Oncology, Prato Hospital, Via Suor Niccolina 20, Prato, Italy.

Classifications MeSH